The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
In article number 1801905, Jinlong Shi, Rongqin Huang, Wei Shi, and co‐workers describe a novel drug‐loaded system, OPPD, which uses PEG and OMCN linked to the Pep22 polypeptide targeting the low‐density lipoprotein receptor, that can effectively cross the blood‐brain barrier and target glioma cells, exerting an outstanding therapeutic efficacy via both the near‐infrared photothermal and chemotherapeutic...
Accumulating studies have investigated the efficacy of receptor‐mediated delivery of hydrophobic drugs in glioma chemotherapy. Here, a delivery vehicle comprising polyethylene glycol (PEG) and oxidized nanocrystalline mesoporous carbon particles (OMCN) linked to the Pep22 polypeptide targeting the low‐density lipoprotein receptor (LDLR) is designed to generate a novel drug‐loaded system, designated...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.